http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
문봉곤,정웅섭,차상목,이창희,박성준,이대희,육인수,박영식,박장현,남욱원,양순철,이선희,이승우,한원용,Moon, B.K.,Jeong, W.S.,Cha, S.M.,Ree, C.H.,Park, S.J.,Lee, D.H.,Yuk, I.S.,Park, Y.S.,Park, J.H.,Nam, U.W.,Matsumoto, Toshio,Yoshida, Seiji,Yang, 한국천문학회 2009 天文學論叢 Vol.24 No.1
MIRIS is the main payload of the STSAT-3 (Science and Technology Satellite 3) and the first infrared space telescope for astronomical observation in Korea. MIRIS space observation camera (SOC) covers the observation wavelength from $0.9{\mu}m$ to $2.0{\mu}m$ with a wide field of view $3.67^{\circ}\times3.67^{\circ}$. The PICNIC HgCdTe detector in a cold box is cooled down below 100K by a micro Stirling cooler of which cooling capacity is 220mW at 77K. MIRIS SOC adopts passive cooling technique to chill the telescope below 200 K by pointing to the deep space (3K). The cooling mechanism employs a radiator, a Winston cone baffle, a thermal shield, MLI (Multi Layer Insulation) of 30 layers, and GFRP (Glass Fiber Reinforced Plastic) pipe support in the system. Optomechanical analysis was made in order to estimate and compensate possible stresses from the thermal contraction of mounting parts at cryogenic temperatures. Finite Element Analysis (FEA) of mechanical structure was also conducted to ensure safety and stability in launching environments and in orbit. MIRIS SOC will mainly perform Galactic plane survey with narrow band filters (Pa $\alpha$ and Pa $\alpha$ continuum) and CIB (Cosmic Infrared Background) observation with wide band filters (I and H) driven by a cryogenic stepping motor.
신기능장애 및 혈액투석환자에서의 Pyrazinamide 의 약력학적 연구
김대중(D . J . Kim),김성권(S . K . Kim),이정상(J . S . Lee),한용철(Y . C . Han),이문호(M . H . Lee),이선희(S . H . Lee),신상구(S . G . Shin),박찬웅(C . W . Park) 대한내과학회 1986 대한내과학회지 Vol.31 No.1
The pharmacokinetics of single oral dose(lgm) of pyrazinamide was studied in 20 patients with various degrees of renal insufficiency including 6 patients on long-term hemodialysis. The average 24 hr urinary recovery of pyrazinamide in patients with creatinine clearance 10 to 30 ml/hr/kg, and patients with creatinine clearance lesser than 10 ml/hr/kg were 7.5 and 0.9% of administered dose respectively. Serum half-life of the drug was slightly, but significantly(p<0.05), prolonged in patients with creatinine clearance lesser than 10 ml/hr/kg(half-life; 11.25±2.55 hr) compared with normal subjects(half-life; 8.21±1.38 hr) previously reported. The mean serm half-life of pyrazinamide in patients on longterm hemodialysis was 12.26±2.92 hr. The half-life fell to 3.52±1.17 hr during hemodialysis. It was estimated that approximately 41% of drug in the body was removed into dialysate during 4 hr dialysis. The mean dialysance of pyrazinamide was 91.40±2.83 ml/min. From the observed pharmacokinetics of pyrazinamide in patients with impaired renal function, it is suggested that adjustment of dosage regimen may not be required for patients just with impaired renal function. However, replacement of dialysed fraction of pyrazinamide would be required for the maintenance of adequate serum level.
감염 ; 우리나라 사람면역결핍바이러스 감염 환자에서 악성종양 발생 양상
설영미 ( Young Mi Seol ),송무곤 ( Moo Gon Song ),최영진 ( Young Jin Choi ),이선희 ( Sun Hee Lee ),김성일 ( Sung Il Kim ),정주섭 ( Joo Seop Chung ),곽임수 ( Ihm Soo Kwak ),조군제 ( Goon Jae Cho ),이혁 ( Hyuck Lee ),정동식 ( Dong S 대한내과학회 2009 대한내과학회지 Vol.76 No.5
목적: 항HIV 치료의 발전으로 HIV 환자가 장기간 생존하게 되면서 악성종양은 HIV 환자에서 중요한 사망원인으로 대두되고 있다. 본 연구는 국내 HIV 환자에서 암 발생양상을 알아보고 이전에 발표된 국내의 연구들과 비교해봄으로서 우리나라 HIV 환자에서 발생하는 암 발생 특성을 파악하는데 도움이 되는 자료를 제시하고자 하였다. 방법: 1990년 1월부터 2008년까지 6월까지 부산지역 4개 대학 병원(고신대병원, 동아대병원, 부산대병원, 인제대병원)에 내원하였던 HIV 감염 환자들을 대상으로 의무기록을 후향적으로 분석하였다. 결과: 대상 환자 683명 중 27명(4%)에서 악성종양이 발생하였다. 27명 중에서 남자는 25명(93%)이었고, 악성종양 진단 시점 연령의 중앙값(범위) 48세(24~76세)였다. 진단 당시 평균 CD4+ 세포수의 중앙값(범위)은 42/uL (3~399)이었다. 비에이즈 정의 악성종양이 14예(52%), 에이즈 정의 악성종양 13예(48%)였다. 시기별로는 Pre-HAART 기간에는 에이즈 정의 악성종양과 비이에즈 정의 악성종양이 각각 2예씩 발생하였고, HAART 기간에는 비에이즈 정의 악성종양이 12예(52%)로 에이즈 정의 악성종양 11예(48%)가 발생하였다. 에이즈 정의 악성종양 중에서는 비호지킨 림프종(9/13)이 가장 많았고, 카포시육종(4/13)의 순이었다. 비호지킨 림프종 중에서는 미만성 B형 대세포 림프종이 가장 많았으며(5/9) 중추신경계 미만성 B형 대세포 림프종 (3/9), 버킷 림프종 (1/9)의 순이었다. 비에이즈 정의 악성종양 중에서는 위암, 직장암, 간세포암이 가장 많았으며(각각 3/14) 그 외 갑상선암, 편도암, 식도암, 혈관육종, 에크린 땀샘암종(eccrine carcinoma)이 각각 1예로, 위장관 기원 악성종양이 50% (7/14)를 차지하였다. 에이즈 정의 악성종양과 비에이즈 정의악성종양 발생 환자의 사이에는 내원 시점 CD4+ 세포수 중앙값은 각각 18, 114/uL로 비에이즈 정의 악성종양 환자에서 의미있게 높았다(p=0.001). 그 외에 성별, 전파경로, HBsAg 양성, 진단 시점 연령, 사망여부, HIV 감염에서 악성종양 진단까지 및 첫 내원부터 악성종양 진단까지 기간은 양 군 간에 의미있는 차이가 없었다. 결론: 국내 HIV 감염 환자의 악성 종양 발병률은 4%였다. 항HIV 치료에 의한 생존율의 향상에 따른 에이즈 악성종양의 감소와 비에이즈 정의 악성종양의 상대적 증가 양상은 관찰되지 않았다. 가장 흔한 악성종양은 비호지킨 림프종이었으며 비에이즈 악성종양 중에서는 소화기계통의 악성종양과 간암이 흔히 발생하였다. Background/Aims: The prevalence of malignancies associated with human immunodeficiency virus (HIV) is rapidly increasing. The aim of the present study was to identify clinical features associated with malignancies in South Korean patients infected with HIV. Methods: From January 1990 to June 2007, we reviewed an electronic database containing pathological reports obtained from HIV-infected patients and then retrospectively analyzed a total of 27 malignancy cases treated at four different institutions. Results: Among 683 patients infected with HIV, malignant diseases were diagnosed in 27 cases (4.0%). Twenty-five of these patients were male, and the median age was 48 (range; 24-76). At the time of diagnosis, the median CD4+ lymphocyte count was 42/uL (range 3-339). Acquired immune deficiency syndrome (AIDS)-defining malignancies were diagnosed in 13 patients (48%) and non-AIDS-defining malignancies were diagnosed in 14 patients (52%). Two patients each were diagnosed with AIDS-defining and non-AIDS-defining malignancies during the pre-highly active anti-retroviral therapy (HARRT) period. In contrast, 11 patients (48%) and 12 patients (52%) were diagnosed with AIDS-defining and non-AIDS-defining malignancies during the HARRT period, respectively. Among AIDS-defining malignancies, non-Hodgkins lymphoma was the most frequently observed (9/13), followed by Kaposi`s sarcoma (4/13). Among the 9 patients with non-Hodgkins lymphoma, diffuse large B-cell lymphoma was most common (5/9), followed by primary CNS lymphoma (3/9) and Burkitt`s lymphoma (1/9). Gastrointestinal (GI) malignancies [i.e., gastric cancer (3/14), rectal cancer (3/14), and esophageal cancer (1/14)] and hepatocellular carcinoma (3/14) were the most commonly observed among the non-AIDS-defining malignancies. Other observed non-AIDS-defining malignancies were thyroid cancer (1/14), tonsillar cancer (1/14), angiosarcoma (1/14), and eccrine cancer (1/14). Finally, median CD4+ lymphocyte counts at the time of diagnosis were significantly different (18 vs. 114/uL, p=0.001) between AIDS-defining malignancies and non-AIDS-defining malignancies. Conclusions: Malignancies were diagnosed in 4.0% of patients infected with HIV. This study showed similar rates of incidence between AIDS-defining and non-AIDS-defining malignancies. Non-Hodgkins lymphoma was the most frequently observed malignancy, whereas GI malignancies and hepatocellular carcinoma were common among non-AIDS-defining malignancies. (Korean J Med 76:554-563, 2009)
일개 농촌 면단위 지역 주민의 보건소 의료이용실태에 관한 조사
위자형,하은희,이선희,조희숙,김정연,김선희,배현아,Wie, C.H.,Ha, E.H.,Lee, S.H.,Jo, Heui-Sook,Kim, J.Y.,Kim, Sun-Hee,Bae, Hyun-A 한국농촌의학지역보건학회 1998 농촌의학·지역보건 Vol.23 No.2
This study was analyzed through the reports which published on the subject matter of Su Dong-Myun from 1994 to 1997 and the medical record of patient in Su-Dong Myun health subcenter. The result are as follow: 1. The number of population in Su-Dong Myun(study area) was 5,475 in 1994, 5,707 in 1995, 6,079 in 1996 and 6,253 in 1997. In composition rate of population, "65 and over" of age group only showed markedly increasing tendancy from 9.8% in l995 to 10.2% in 1997. However, the rest of all age group showed decreasing tendancy. 2. Annual utilization rate showed decreasing tendancy, such as 247 in 1994. 203 in 1995, 146 in 1996, and 140 in 1997 per 1000 population. But visiting time is increasing tendency, such as 3.1 in 1994, 2.8 in 1995. 2.4 in 1996 and 3.4 in 1997 per disease case. 3. Age specific annual utilization rate, all age showed decreasing tendancy in the age group of "0-14", "15-44" and "45-64", however showed increasing tendency in the age group of "65 and over" from 1994 to 1997. 4. The major disease were disease of Respiratory system. Gastrointestinal system. Musculoskeletal system and Connective tissue. Skin and Subcutaneous tissue and Circulatory system The disease of Musculoskeletal system and Connective tissue and Circulatory system are increasing.